Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,652.46
+12.420.47%
Number of Gainers:40
Number of Losers:57
Number of Flat:1
PE:- -
High:2,660.57
Open:2,640.14
Low:2,637.18
Close:2,640.03
Volume:1.87B
Turnover:402.39B
Market Cap:48.55T
Float Cap:45.07T

Loading ...

ADP, Amazon Web Services announce expanded partnership

TIPRANKS
·
Sep 08

Analysts Offer Insights on Consumer Goods Companies: Walmart (WMT) and Mama’s Creations (MAMA)

TIPRANKS
·
Sep 08

ADP Expands Strategic Partnership with AWS to Accelerate AI-Powered HCM Innovation

Reuters
·
Sep 08

Verizon, Corning enter multi-billion dollar agreement for 80M miles of fiber

TIPRANKS
·
Sep 08

Qualcomm Stock Jumps 8% Thanks to Deal with Amazon

Dow Jones
·
Sep 08

Orchestra BioMed Highlights $500 Million-Plus Annual Royalty Potential from Medtronic-Partnered AVIM Pacemaker Therapy

Reuters
·
Sep 08

Qualcomm to issue warrant to Amazon.com for up to 25M shares

TIPRANKS
·
Sep 08

Navan, Engine announce strategic technology partnership

TIPRANKS
·
Sep 08

Amazon and AT&T Team up to Challenge SpaceX's Satellite Dominance

Dow Jones
·
Sep 08

Why Micron Stock is Popping on Fresh Memory-Chip Price Data

Dow Jones
·
Sep 08

Accenture, Google Cloud launch Accenture Gemini Enterprise Business Group

TIPRANKS
·
Sep 08

Qualcomm Shares up 10.1% Premarket After Co, Amazon to Develop Custom Chips for AI Data Centers

THOMSON REUTERS
·
Sep 08

AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab

TIPRANKS
·
Sep 08

Qualcomm announces multi-generation collaboration with Amazon.com

TIPRANKS
·
Sep 08

Qualcomm Partners with Amazon on Multi-Generation Custom Chips for AWS AI Data Centers

Reuters
·
Sep 08

Notable open interest changes for September 8th

TIPRANKS
·
Sep 08

Amgen - Phase 3 Dellphi-305 Study Delivers Significant Overall Survival Benefit Versus Durvalumab Alone

THOMSON REUTERS
·
Sep 08

Imdelltra® in Combination with Imfinzi® Demonstrated Landmark Improvement in Overall Survival in First-Line Extensive Stage Small Cell Lung Cancer

THOMSON REUTERS
·
Sep 08

Amgen - Study Meets Secondary Endpoints for Progression-Free Survival and Objective Response Rate

THOMSON REUTERS
·
Sep 08

Amgen - no New or Unexpected Safety Signals Identified in Dellphi-305 Study

THOMSON REUTERS
·
Sep 08